Selection of Neuroprotective Therapy in Patients with Chronic Cerebral Ischemia Taking Account of the Synergism of Drug Interactions

作     者：Gromova, O.A. Torshin, I. Yu. Putilina, M.V. Semenov, V.A. Rudakov, K.V. 

作者机构：Institute of Pharmacoinformatics Informatics and Management Federal Research Center Russian Academy of Sciences Moscow Russian Federation Center for Storage and Analysis of Big Data Lomonosov Moscow State University Moscow Russian Federation Pirogov Russian National Research Medical University Russian Ministry of Health Moscow Russian Federation Kemerovo State Medical University Russian Ministry of Health Kemerovo Russian Federation 

出 版 物：《Neuroscience and Behavioral Physiology》 (Neurosci. Behav. Physiol.)

年 卷 期：2021年第51卷第4期

页      面：430-437页

学科分类：0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 10[医学] 

主　　题：choline alfoscerate Citicoline Cytoflavin ethylmethylhydroxypyridine succinate intelligent data analysis peptide drugs pharmacoinformatics piracetam synergism 

摘      要：Objective. To optimize selection of neuroprotective treatment protocols in patients with chronic cerebral ischemia taking account of synergism in drug interactions for an individual personalized approach to increase treatment efficacy. Materials and Methods. Differential chemoreactome analysis of synergism between ethylmethylhydroxypyridine succinate (EMHPS) and a number of single-component neuroprotective substances (piracetam, vinpocetine, citicoline, choline alfoscerate);proteome analysis of polypeptide neuroprotectors (Cerebrolysin and others);expert analysis of the composition of a multicomponent neuroprotector (Cytoflavin). Results. Piracetam, citicoline (Neupilept), and choline alfoscerate (Cereton) effectively enhanced the pharmacological properties of EMHPS. Expert assessments of synergism between the properties of EMHPS, polypeptide neuroprotectors (Cerebrolysin), and other multicomponent formulations (Cytoflavin), which are also used in the adjuvant therapy in combination with EMHPS, are presented. Conclusions. In real clinical practice there is particular interest in objective evaluation of combined treatment protocols. EMHPS can provide a favorable background for maximizing treatment efficacy using additional drugs. © 2021, Springer Science+Business Media, LLC, part of Springer Nature.